Activated STING in a Vascular and Pulmonary SyndromeYu Liu, Manfred Boehm, Klaus Tenbrock et al.|New England Journal of Medicine|2014Cited by 1.4k
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Adam Reinhardt et al.|Journal of Clinical Investigation|2018Cited by 519
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory SyndromeHratch Baghdassarian, Lori Broderick, Sarah A. Blackstone et al.|New England Journal of Medicine|2023Cited by 78